Kestra Medical Technologies, Ltd. (KMTS)

KMTS Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2021	Apr 30, 2020
Net Income	-113.81	-94.12	-84.24	-34.1	-29.47
Depreciation & Amortization	7.97	11.56	4.86	0.42	0.48
Other Amortization	1.4	0.61	0.45	0.15	-
Loss (Gain) From Sale of Assets	2.09	1.07	0.56	-0	0
Stock-Based Compensation	24.27	1.49	1.21	1.86	-
Provision & Write-off of Bad Debts	2.69	0.5	-	-	-
Other Operating Activities	3.98	2.77	6.23	1.79	0.7
Change in Accounts Receivable	-8.78	-2.5	-	-	-
Change in Inventory	-3.44	-1.18	-0.73	-	-
Change in Accounts Payable	2.84	7.34	2.14	-0.13	-0.79
Change in Other Net Operating Assets	3.18	0.22	-0.11	0.11	-1.22
Operating Cash Flow	-77.61	-72.24	-69.64	-29.9	-30.29
Capital Expenditures	-23.59	-12.51	-15.46	-0.34	-0.23
Sale of Property, Plant & Equipment	-	-	-	0	-
Other Investing Activities	0.28	0.29	-	-	-
Investing Cash Flow	-23.31	-12.23	-15.46	-0.33	-0.23
Long-Term Debt Issued	-	45	-	20	-
Long-Term Debt Repaid	-	-39.12	-5.33	-	-
Net Debt Issued (Repaid)	-	5.88	-5.33	20	-
Issuance of Common Stock	218.16	-	-	30.33	30.42
Other Financing Activities	8.7	-3.15	-0.67	-1.52	-0.18
Financing Cash Flow	330.26	77.73	96.11	48.82	30.24
Net Cash Flow	229.35	-6.74	11	18.59	-0.29
Free Cash Flow	-101.2	-84.75	-85.1	-30.23	-30.53
Free Cash Flow Margin	-169.19%	-304.70%	-1115.37%	-	-
Free Cash Flow Per Share	-4.12	-4.26	-804.32	-285.72	-288.49
Cash Interest Paid	4.85	3.63	-	-	-
Cash Income Tax Paid	0.08	-0.03	0.01	0.21	0.07
Levered Free Cash Flow	-67.53	-40.92	-	-18.53	-
Unlevered Free Cash Flow	-64.1	-37.63	-	-17.95	-
Change in Net Working Capital	6.26	-15	-	-0.54	-

Updated Apr 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q